Neogen (NEOG) Net Income towards Common Stockholders (QoQ) (2010 - 2026)
Neogen (NEOG) Net Income towards Common Stockholders (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | Neogen | 2.03 Bn | 1.87 Bn | 99.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -6.76% |
| Nov 30, 2025 | -143.82% |
| Aug 31, 2025 | 105.58% |
| May 31, 2025 | -5,876.50% |
| Feb 28, 2025 | 97.61% |
| Nov 30, 2024 | -3,518.70% |
| Aug 31, 2024 | -132.85% |
| May 31, 2024 | -167.80% |
| Feb 29, 2024 | 42.01% |
| Nov 30, 2023 | -332.00% |
| Aug 31, 2023 | -76.45% |
| May 31, 2023 | -22.08% |
| Feb 28, 2023 | 119.57% |
| Nov 30, 2022 | -903.24% |
| Aug 31, 2022 | -63.36% |
| May 31, 2022 | 161.18% |
| Feb 28, 2022 | -49.73% |
| Nov 30, 2021 | -36.59% |
| Aug 31, 2021 | 19.09% |
| May 31, 2021 | 7.20% |